Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_assertion type Assertion NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_head.
- NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_assertion description "[We found that EMT developed in a lung cancer patient who had an acquired resistance to erlotinib while there were no known resistant mechanisms such as T790M and MET amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_provenance.
- NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_assertion evidence source_evidence_literature NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_provenance.
- NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_assertion SIO_000772 21168239 NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_provenance.
- NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_assertion wasDerivedFrom befree-20140225 NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_provenance.
- NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_assertion wasGeneratedBy ECO_0000203 NP395122.RAo5QOhLQVmbLU_-a-AYQWlf_a3i0Fq1lJXtThiqV1OIM130_provenance.